BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 106 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $57,000 | +42.5% | 9,000 | 0.0% | 0.01% | +37.5% |
| Q3 2016 | $40,000 | +53.8% | 9,000 | 0.0% | 0.01% | +33.3% |
| Q2 2016 | $26,000 | +4.0% | 9,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $25,000 | -73.1% | 9,000 | 0.0% | 0.01% | -73.9% |
| Q4 2015 | $93,000 | -9.7% | 9,000 | 0.0% | 0.02% | -14.8% |
| Q3 2015 | $103,000 | -42.5% | 9,000 | -25.0% | 0.03% | -41.3% |
| Q2 2015 | $179,000 | +65.7% | 12,000 | 0.0% | 0.05% | +70.4% |
| Q1 2015 | $108,000 | -26.0% | 12,000 | 0.0% | 0.03% | -30.8% |
| Q4 2014 | $146,000 | +24.8% | 12,000 | 0.0% | 0.04% | +8.3% |
| Q3 2014 | $117,000 | -23.5% | 12,000 | 0.0% | 0.04% | -25.0% |
| Q2 2014 | $153,000 | +20.5% | 12,000 | 0.0% | 0.05% | +11.6% |
| Q1 2014 | $127,000 | +39.6% | 12,000 | 0.0% | 0.04% | +30.3% |
| Q4 2013 | $91,000 | +4.6% | 12,000 | 0.0% | 0.03% | -8.3% |
| Q3 2013 | $87,000 | +357.9% | 12,000 | 0.0% | 0.04% | +300.0% |
| Q2 2013 | $19,000 | +35.7% | 12,000 | 0.0% | 0.01% | +28.6% |
| Q1 2013 | $14,000 | -17.6% | 12,000 | 0.0% | 0.01% | -36.4% |
| Q4 2012 | $17,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |